Related Experiment Video
Updated: May 10, 2026
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Drug-induced valvular heart disease: an update
Michel Andrejak1, Christophe Tribouilloy
1Service de pharmacologie clinique, hôpital Sud, CHU d'Amiens, avenue René-Laennec, Salouel, 80054 Amiens cedex 1, France. andrejak.michel@chu-amiens.fr
Archives of Cardiovascular Diseases
|June 18, 2013
Summary
Drug-induced valvular heart disease is linked to ergot alkaloids, dopaminergic agonists, and fenfluramine derivatives. This review details the drugs, features, and mechanisms of this condition.
Area of Science:
- Cardiology
- Pharmacology
- Toxicology
Background:
- Fibrotic valve disease has been linked to specific drug classes.
- Ergot alkaloids, dopaminergic agonists, and fenfluramine derivatives are implicated.
- Understanding this association is crucial for patient safety.
Purpose of the Study:
- To review the historical context of drug-induced valvular heart disease.
- To describe the echocardiographic characteristics of this condition.
- To identify drugs associated with valvular heart disease and explore their pathophysiology.
Main Methods:
- Literature review of reported cases and studies.
- Analysis of drug classes and their mechanisms.
- Examination of echocardiographic findings in affected patients.
Main Results:
- Established association between ergot alkaloids (methysergide, ergotamine), ergot-derived dopaminergic agonists (pergolide, cabergoline), and drugs metabolized into norfenfluramine (fenfluramine, dexfenfluramine, benfluorex) and fibrotic valve disease.
- Echocardiographic features characteristic of drug-induced valvular heart disease.
- Insights into the pathophysiological pathways linking these drugs to cardiac valve damage.
Conclusions:
- Certain medications pose a significant risk for developing fibrotic valve disease.
- Awareness of these drugs and their potential cardiac toxicity is essential for clinicians.
- Further research into the precise mechanisms is warranted.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...